Oil up for the week, down for the day as China concerns offset Middle East turmoil
https://seekingalpha.com/news/4056638-oil-up-for-the-week-down-for-the-day-as-china-concerns-offset-middle-east-turmoil?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Jan 19, 2024 - Crude oil prices were rangebound this week as concerns about China's economic growth offset Middle East tensions.
0
Yields Up To 9.2%: Lifelong Passive Income From Enbridge And MPLX
https://seekingalpha.com/article/4663986-yields-up-to-9-2-percent-lifelong-passive-income-from-enbridge-and-mplx?source=feed
Jan 21, 2024 - Discover the top dividend stocks for generating passive income.
0
Silynxcom gets follow-up order for headsets worth $400k
https://seekingalpha.com/news/4057398-silynxcom-gets-follow-up-order-for-headsets-worth-400k?source=feed_tag_israel
Jan 23, 2024 - Silynxcom secures $400,000 follow-up order from major defense company, bringing total orders to over $4.5 million.
0
Samsung, Apple race to shake up glucose monitoring market: Bloomberg
https://seekingalpha.com/news/4057426-samsung-apple-race-shake-up-glucose-monitoring-market?source=feed_sector_healthcare
Jan 23, 2024 - Samsung(SSNLF) is developing blood glucose monitoring technology to compete with Apple (AAPL) in a market dominated by the likes of Medtronic (MDT). Read more here.
0
College enrollment picks up for the first time in over a decade — but student loan debt is still a major sticking point
https://www.cnbc.com/2024/01/24/college-enrollment-picks-up-but-student-loan-debt-is-still-a-sticking-point.html
Jan 24, 2024 - More students went to college this fall, but there's been a shift toward shorter-term programs over four-year degrees.
0
Prime Medicine wins up to $15M to find cure for cystic fibrosis
https://seekingalpha.com/news/4058670-prime-medicine-stock-rises-funds-cystic-fibrosis-cure?source=feed_sector_healthcare
Jan 25, 2024 - Prime Medicine (PRME) wins up to $15M from the Maryland-based non-profit Cystic Fibrosis Foundation to develop a one-time therapy for cystic fibrosis. Read more here.
0
REV To Exit School, Transit Bus Manufacturing; Announces Dividend; Stock Up In Pre-market
https://www.rttnews.com/story.aspx?Id=3419795
Jan 29, 2024 - Specialty vehicles maker REV Group, Inc. (REVG) announced Monday its plans to exit school and transit bus manufacturing, and to reorganize into two reporting segments. Further, the company announced a special cash dividend.
0
Agree Realty: Who Else Is Backing Up The Truck With Me?
https://seekingalpha.com/article/4665843-agree-realty-who-else-is-backing-up-the-truck-with-me?source=feed
Jan 30, 2024 - Agree Realty focuses on e-commerce-resistant national and super-regional retailers, providing safety and stability. Find out what makes ADC stock a buy.
0
Alibaba: Don't Follow Jack Ma - Why I'm Giving Up (Rating Downgrade)
https://seekingalpha.com/article/4666047-alibaba-dont-follow-jack-ma-why-im-giving-up-rating-downgrade?source=feed_tag_editors_picks
Jan 30, 2024 - Alibaba has made minimal progress on spinning out its business segments. Learn why I'm downgrading BABA stock to hold.
0
Why UPS Stock Is Rolling Downhill Today
https://www.fool.com/investing/2024/01/30/why-ups-stock-is-rolling-downhill-today/?source=iedfolrf0000001
Jan 30, 2024 - The company's guidance for 2024 underwhelmed.
0